Clinical Report: Case Study of Multidrug-Resistant Tuberculosis in Women
Overview
This report presents a rare case of multidrug-resistant tuberculosis (MDR-TB) affecting both breast and uterine adnexa in a 33-year-old woman, highlighting the need for increased awareness and early diagnostic measures in atypical presentations.
Background
Multidrug-resistant tuberculosis (MDR-TB) poses a significant public health challenge, with approximately 400,000 cases reported globally in 2023. Extrapulmonary tuberculosis, particularly involving the breast and female genital tract, is rare, accounting for 15-20% of all TB cases, and often misdiagnosed due to nonspecific clinical manifestations. Awareness of atypical presentations is crucial for timely diagnosis and effective treatment.
Data Highlights
No numerical data available in the source material.
Key Findings
The patient presented with breast pain and distention, initially misdiagnosed as mastitis. Ultrasound findings revealed multiple lesions in the breast and adnexa, leading to delayed diagnosis. Persistent discharge and delayed wound healing post-surgery indicated a more serious underlying condition. Concurrent infections were identified in the lungs, complicating the clinical picture. Only one previous case of breast MDR-TB was reported in the literature, emphasizing the rarity of this condition.
Clinical Implications
Healthcare providers should consider MDR-TB in differential diagnoses for patients with atypical breast or adnexal lesions, especially when initial treatments fail. Early microbiological testing and drug susceptibility testing are essential to avoid misdiagnosis and ensure appropriate management.
Conclusion
This case underscores the need for heightened awareness and prompt diagnostic measures for MDR-TB in atypical presentations, which can significantly impact patient outcomes.
